STOCK TITAN

TerrAscend Reschedules November 6th Third Quarter 2025 Earnings Conference Call to Pre-Open from Post-Market Close

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

TerrAscend (OTCQX: TSNDF) rescheduled its third quarter 2025 earnings conference call to Thursday, November 6, 2025 at 8:30 a.m. ET. The company will report financial results for the quarter ended September 30, 2025 earlier that day in advance of the call. Investors can join via webcast or dial-in; a replay will be available until midnight ET on Thursday, November 20, 2025.

Conference details: Webcast: https://app.webinar.net/6dvVkb2k4bz. Dial-in: 1-888-510-2154. Replay numbers: 1-289-819-1450 or 1-888-660-6345 with entry code 73897#.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

+5.99% News Effect

On the day this news was published, TSNDF gained 5.99%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

TORONTO, Oct. 22, 2025 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis company, today announced that it has rescheduled its November 6, 2025 earnings conference call to discuss the results for the third quarter ended September 30, 2025. The call will still be held on Thursday, November 6, 2025, but will take place at 8:30 a.m. Eastern Time. The Company will report its financial results for the third quarter 2025 on the same day in advance of the call. The rescheduling is due to a conflict with the originally scheduled time.

REVISED CONFERENCE CALL DETAILS

  
Date:Thursday, November 6, 2025
Time:8:30 a.m. Eastern Time
Webcast:https://app.webinar.net/6dvVkb2k4bz
Dial-in Number:1-888-510-2154
Replay:



1-289-819-1450 or 1-888-660-6345

Available until 12:00 midnight Eastern Time on Thursday, November 20, 2025
Replay Entry Code: 73897#


About TerrAscend

TerrAscend is a leading TSX-listed cannabis company with interests across the North American cannabis sector, including operations in Pennsylvania, New Jersey, Maryland, Ohio, and California through TerrAscend Growth Corp. and retail operations in Canada. TerrAscend operates The Apothecarium and other dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. TerrAscend’s cultivation and manufacturing practices yield consistent, high-quality cannabis, providing industry-leading product selection to both the medical and legal adult-use markets. The Company owns or licenses several synergistic businesses and brands including The Apothecarium, Cookies, Lemonnade, Ilera Healthcare, Kind Tree, Legend, State Flower, Wana, and Valhalla Confections. For more information visit www.terrascend.com.

For more information regarding TerrAscend:
Ziad Ghanem
Chief Executive Officer
IR@terrascend.com
689-345-4114
IR@terrascend.com

Investor Relations Contact:
KCSA Strategic Communications
Valter Pinto, Managing Director
Valter@KCSA.com 
212-896-1254


FAQ

When will TerrAscend (TSNDF) report Q3 2025 results and hold the earnings call?

TerrAscend will report Q3 2025 results and host the earnings call on November 6, 2025; the call is at 8:30 a.m. ET.

How can investors join the TerrAscend (TSNDF) November 6, 2025 earnings call?

Join via webcast at https://app.webinar.net/6dvVkb2k4bz or dial in at 1-888-510-2154.

Will there be a replay of the TerrAscend (TSNDF) Q3 2025 earnings call and how long is it available?

Yes. Replay is available until midnight ET on November 20, 2025 via 1-289-819-1450 or 1-888-660-6345 using entry code 73897#.

Why was the TerrAscend (TSNDF) November 6, 2025 call rescheduled to pre-market?

The company said the call was rescheduled due to a timing conflict with the originally scheduled time.

What quarter does the TerrAscend (TSNDF) November 6, 2025 call cover?

The call will discuss results for the third quarter ended September 30, 2025.

Who can I contact for investor relations questions about TerrAscend (TSNDF)?

Investor relations contacts include the CEO Ziad Ghanem and KCSA Strategic Communications managing director Valter Pinto; email IR@terrascend.com or Valter@KCSA.com.
Terrascent

OTC:TSNDF

TSNDF Rankings

TSNDF Latest News

TSNDF Latest SEC Filings

TSNDF Stock Data

298.73M
219.57M
6.31%
2.36%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
King of Prussia